RPL12P33

Across TCGA pan-cancer cohorts, RPL12P33 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated RPL12P33 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher RPL12P33 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPL12P33 expression acts as an unfavorable survival marker, although some lineages such as SKCM and CESC show a favorable association.

ACC, OV, and SKCM are the cancer types where RPL12P33 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Median	All	0.232	0.632	<.001	83	view →
OV	OS	Tertile	All	0.270	0.368	.005	30	view →
SKCM	OS	Tertile	All	0.827	0.681	.002	29	view →
SARC	OS	Tertile	All	0.630	0.822	<.001	28	view →
CESC	DFS	Tertile	III,IV	0.762	0.349	.029	14	view →
CHOL	OS	Quartile	All	0.826	0.378	.016	13	view →
PAAD	OS	Median	II,III,IV	0.629	0.249	.005	12	view →
ESCA	OS	Median	IV	0.698	0.222	.006	12	view →
THCA	OS	Tertile	II,III,IV	1.000	0.971	.015	8	view →
LUAD	OS	Tertile	III,IV	0.266	0.636	.007	8	view →
KICH	DFS	Median	All	0.809	0.971	.022	7	view →
UVM	DFS	Median	All	0.693	0.442	.041	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

RPL12P33–ACC (DFS)

Open the ACC breakdown →